Yokohama Capital
Yokohama Capital is a Yokohama-headquartered venture capital and private equity firm, wholly owned by Yokohama Bank (Yokohama Financial Group), providing equity investment, business succession/buyout financing, and turnaround support for startups and SMEs across Kanagawa and Tokyo.
- Company typePrivate
- Founded1984
- HeadquartersYokohama, Japan
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What Yokohama Capital does
Yokohama Capital Co., Ltd. (横浜キャピタル株式会社) is a Japan-based venture capital and private equity firm founded in March 1984 as a wholly-owned subsidiary of Yokohama Bank (Bank of Yokohama), now operating under Yokohama Financial Group. The firm provides equity investment and management support across three core strategies: venture and growth-stage investment for startups, business succession and buyout investment for small and medium-sized enterprises, and business regeneration (turnaround) investment for companies requiring restructuring. Its primary catchment is Kanagawa Prefecture and the Tokyo metropolitan area, supplemented by a cross-regional partnership with Chiba Bank covering Chiba Prefecture.
The firm operates a multi-vehicle fund platform totaling roughly ¥210B in disclosed AUM, anchored by Yokohama Growth1号 (¥30B, venture/growth, established September 2024), Yokohama Next (¥60B, versatile VC and succession, March 2023), Yokohama Next2号 (¥50B, buyout/succession/regeneration, September 2024), the Chiba-Yokohama Partnership 1号 Fund (March 2021), and the Kanagawa SME Support Fund (¥20B, January 2019), plus legacy vehicles including Mirai Regional Activation and Kanagawa Tourism Activation. LPs include Yokohama Bank, Hamgin Finance, Hamgin Sogo Research Institute, Chiba Bank, the Development Bank of Japan, and the Organization for Small & Medium Enterprises. Co-investment with regional financial institutions and policy-aligned agencies is a structural feature rather than an exception.
Portfolio construction spans seed-to-Series A opportunities across biotech/pharma (Reborna Biosciences, Eurus Therapeutics, PURMX Therapeutics, Lekmed), clean energy/GX (PXP perovskite-chalcopyrite tandem solar, EV Motors Japan), space tech (Pale Blue water-propellant ion thrusters, Iwaya Giken high-altitude balloons), AI/data services (NABLA Mobility for aviation decarbonization, any Inc./Qast knowledge management, GVA TECH legal AI), Web3 (JPYC yen stablecoin), IoT (Nature Remo), cultivated meat (Integriculture), and agricultural robotics (Regmin). Revenue mechanics consist of traditional VC management fees on committed/invested capital across active funds and capital appreciation/realized carry from exits. The firm references an IPO track record of more than 100 companies between 1988 and 2024 across TSE (First Section, Growth/Mothers) and JASDAQ venues. Distribution relies almost exclusively on parent-bank channel — Yokohama Bank's Kanagawa/Tokyo branch network drives deal origination, post-investment business matching, and limited-partner support; the firm operates from a single headquarters in Minato Mirai, Yokohama, and joined the Japan Venture Capital Association in June 2023.
Yokohama Capital firmographics
Firmographics- Name
- Yokohama Capital
- Legal name
- 横浜キャピタル株式会社 (Yokohama Capital Co., Ltd.)
- Website
- https://yokohama-capital.co.jp/
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Yokohama Capital is a Yokohama-headquartered venture capital and private equity firm, wholly owned by Yokohama Bank (Yokohama Financial Group), providing equity investment, business succession/buyout financing, and turnaround support for startups and SMEs across Kanagawa and Tokyo.
- Ownership category
- akta.pro rank
Where Yokohama Capital is headquartered
LocationHeadquarters
- HQ city
- Yokohama
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
Yokohama Capital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Fund Management Fees: Yokohama Capital earns management fees from operating investment funds. The firm manages multiple funds with total AUM of 210 billion yen across active funds including Yokohama Growth1号 (30 billion yen), Yokohama Next2号 (50 billion yen), and Yokohama Next (60 billion yen).
- Investment Returns / Capital Gains: The firm generates returns through equity investments in portfolio companies, benefiting from IPO exits and capital appreciation. Historical IPO track record includes over 100 companies that have gone public.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Yokohama Capital product offering
Product offeringCore offering
Yokohama Capital provides equity investment and post-investment management support to startups, growth-stage companies, and SMEs through multiple dedicated investment funds. Core activities span three categories: venture/growth investment supporting startup expansion, business succession and buyout investment enabling ownership transition, and business regeneration investment supporting corporate turnaround scenarios. Total assets under management amount to 210 billion yen across active funds, with a historical track record of over 100 portfolio company IPOs since 1988.
Product overview
Yokohama Capital (横浜キャピタル株式会社) is a venture capital and private equity firm established in 1984 as a subsidiary of Yokohama Bank (now part of Yokohama Financial Group). The company operates a diversified portfolio of investment funds including venture capital funds (Yokohama Growth1号, Yokohama Next), buyout/succession funds (Yokohama Next2号), and regional partnership funds. Their investment focus areas span startups, growth companies, and companies requiring business succession support across Kanagawa Prefecture and Tokyo. The portfolio includes knowledge management platforms (Qast), aviation optimization AI solutions (NABLA Mobility), renewable energy technology (PXP solar cells), and biotech/pharmaceutical ventures (Reborna Biosciences, Eurus Therapeutics, PURMX Therapeutics, Recmed, Varinos).
Differentiator
Problem solved
Functional benefit
Products and services
- Yokohama Growth 1号 Fund (横浜キャピタル Growth 1号投資事業有限責任組合) A venture capital and growth support fund targeting startups and growth-stage companies seeking equity capital in Kanagawa Prefecture and surrounding areas. Fund size 3 billion yen; 10-year investment period.
- Yokohama Next 2号 Fund (Yokohama Next 2号投資事業有限責任組合) A buyout, business succession, and business revitalization fund providing equity capital for SMEs requiring ownership transition or turnaround support. Fund size 5 billion yen.
- Yokohama Next Fund (Yokohama Next投資事業有限責任組合) A versatile investment fund supporting venture capital, growth equity, and interim ownership arrangements for business succession or transfer purposes. Fund size 6 billion yen.
- Chiba-Yokohama Partnership 1号 Fund (千葉・横浜パートナーシップ1号投資事業有限責任組合) A regional partnership fund co-established with Chiba Bank targeting business succession and growth investment opportunities for SME customers of both banks across Kanagawa and Chiba prefectures.
- Kanagawa SME Support Fund (かながわ中小企業支援ファンド投資事業有限責任組合) A 2 billion yen fund providing medium-to-long-term equity participation support to SMEs in Kanagawa Prefecture, in collaboration with regional financial institutions and the SME Agency.
Quantifiable outcome
- Over 100 IPO successes spanning 1988-2024
- +2 more outcomes
Companies that use Yokohama Capital
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Yokohama Capital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Yokohama Capital partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights7 records
Yokohama Capital competitors and assessment
Company assessmentDirect peers
- Mizuho Capital: VC subsidiary of Mizuho Financial Group. Directly comparable bank-affiliated VC with multi-fund strategy across venture, growth, and succession investments in Japan.
- Chiba Capital: Investment arm of Chiba Bank, which is itself an LP partner of Yokohama Capital in the Chiba-Yokohama Partnership Fund. Comparable as a regional bank-affiliated VC operating in adjacent Japanese geography.
- DBJ Capital: VC arm of the Development Bank of Japan. Notably DBJ is already an LP partner of Yokohama Capital in the Tsunagu Business Succession Fund, making this a co-LP and direct operational peer.
- Daiwa Corporate Investment: Investment arm of Daiwa Securities Group, providing equity capital to Japanese startups and SMEs including succession/MBO deals. Comparable as a financial-group-affiliated VC/PE firm with diversified strategy.
- Nissay Capital: Wholly-owned VC subsidiary of Nippon Life Insurance, providing equity capital and management support to Japanese startups and growth companies. Closest structural analogue — a large insurance/financial group's VC arm — making it a directly comparable bank/insurer-affiliated VC.
- Mitsubishi UFJ Capital: VC arm of Mitsubishi UFJ Financial Group, one of Japan's mega-banks. Comparable bank-affiliated VC operating multiple funds targeting venture and growth-stage Japanese companies.
- SMBC Venture Capital: VC arm of Sumitomo Mitsui Banking Corporation. Comparable as a bank-affiliated VC with national deal flow and multi-fund operations targeting startups and growth-stage companies.
Broad incumbents
- SBI Investment: One of Japan's largest VC/PE managers, operating numerous venture, growth, and buyout funds with a national footprint. Comparable in strategy but materially larger in AUM and brand recognition.
- JAFCO Group: Japan's largest venture capital and buyout firm with >¥500B AUM. Directly comparable as it operates VC, growth, and buyout/succession funds across Japan; far larger scale but same multi-strategy VC/PE model.
Emerging players
- Globis Capital Partners: Independent VC firm affiliated with the Globis group, focused on Japanese growth-stage startups. Comparable as a Japanese VC investor but operates independently rather than as a bank subsidiary.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Yokohama Capital financial estimates
Financial estimateRevenue estimate
Valuation estimate
Yokohama Capital leadership team
Management profileNumber of profiles
Profiles2 records
Yokohama Capital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Yokohama Capital M&A and investment
M&A and investmentM&A
Investments54 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Yokohama Capital
What does Yokohama Capital do?
Yokohama Capital provides equity investment and post-investment management support to startups, growth-stage companies, and SMEs through multiple dedicated investment funds. Core activities span three categories: venture/growth investment supporting startup expansion, business succession and buyout investment enabling ownership transition, and business regeneration investment supporting corporate turnaround scenarios. Total assets under management amount to 210 billion yen across active funds, with a historical track record of over 100 portfolio company IPOs since 1988.
Is Yokohama Capital a public or private company?
Yokohama Capital is a private company. It is classified as corporate owned and is currently operating.
When was Yokohama Capital founded?
Yokohama Capital was founded in 1984. It employs 1,001 to 5,000 people.
Where is Yokohama Capital based?
Yokohama Capital is headquartered in Yokohama, Japan, in the Asia region.
How does Yokohama Capital make money?
Two revenue lines are on record. Fund Management Fees are the primary driver. The others are investment Returns / Capital Gains.
Who are Yokohama Capital's main competitors?
Direct peers on record are Mizuho Capital, Chiba Capital, DBJ Capital, Daiwa Corporate Investment, Nissay Capital, Mitsubishi UFJ Capital and SMBC Venture Capital. Broad incumbents are SBI Investment and JAFCO Group. Globis Capital Partners is listed as an emerging player.
Does Yokohama Capital have an API?
No public API is recorded for Yokohama Capital.